Pulse Biosciences Welcomes New Talent with Stock Options

Pulse Biosciences, a company renowned for its innovative nPulse™ technology, has taken a strategic step to attract new talent. The company has granted stock options to three new employees, allowing them to purchase up to 13,450 shares of the company's stock.

Key Details of the Stock Options

• Exercise Price: $13.58 per share
• Exercise Date: November 18, 2025
• Vesting Schedule: The options will vest over four years, with 25% vesting each year. Employees must remain with the company to fully benefit from these options.

The Compensation Committee approved these awards to incentivize the new employees to join. This move is in compliance with Nasdaq Listing Rule 5635(c)(4) and is part of the 2017 Inducement Equity Incentive Plan.

Innovation in Healthcare

Pulse Biosciences is at the forefront of healthcare innovation with its nPulse™ technology. This technology uses nanosecond pulses of electrical energy to clear cells without damaging surrounding tissue. The company is exploring various applications, including:

• Treating atrial fibrillation
• Potential uses in other markets

Trademarks and Intellectual Property

Pulse Biosciences holds several trademarks, including:

• Pulse Biosciences
• nPulse
• Vybrance
• CellFX

These trademarks are registered in the United States and other countries.